An open label study to assess the effectiveness of oral methotrexate in reducing pain in knee osteoarthritis

Mise à jour : Il y a 5 ans
Référence : EUCTR2008-008237-11

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Primary outcome: Change in WOMAC pain score at 24 weeks (Western Ontario and McMasters Universities Index) To judge the effectiveness of methotrexate at reducing pain in the osteoarthritic knee joint after 24 weeks of treatment, by reducing synovitis in the joint.


Critère d'inclusion

  • Painful osteoarthritis of the knee joint

Liens